CNV analysis showed that UBR2, UBR4, and UBR5 were positive for copy-number amplification in patients with HCC from the TCGA database (amplification frequency > 1%), with UBR5 significantly showing the maximum gain (Fig. 1A). Here, UBR5 is linked to hepatocellular carcinoma.